The Elevator Pitch

TRIBUTE PROVISIONS

CHARLOTTESVILLE

Founder: Holt Walker
Founded: 2025
Capital raised: $0
Employees: 1
Service provided: Clean-ingredient, high-protein cereal

What makes your company different?

Tribute was built around a stricter ingredient standard than both conventional cereals and most high-protein cereals. We use organic, grass-fed whey as our protein source, which provides a complete protein with all amino acids. We also avoid the common shortcuts in the category, including seed oils, so-called natural flavors, gums and emulsifiers.

That combination is what sets Tribute apart. In cereal, consumers are often forced to choose between better macros and better ingredients. Conventional cereals typically fall short on protein and ingredient quality, while most protein cereals improve macros but still rely on heavily processed formulations and additive-driven ingredient decks.

Tribute is designed to close that gap by delivering meaningful protein and a cleaner ingredient standard in the same product.

The pitch: Tribute is a clean-ingredient, high-protein cereal built as a daily staple. We use real ingredients and deliver 12 grams of protein. Sugar is kept intentionally low.

The opportunity is to rebuild a legacy category that has drifted toward ultra-processed formulations. Consumers are increasingly looking for everyday foods they can trust, but options that combine strong nutrition with a clean ingredient standard are still limited.

Tribute is designed to fill that gap with a product people can eat regularly, whether it’s breakfast, a snack or an evening bowl, without second-guessing what’s in it.

We are launching direct-to-consumer, using rapid iteration and real-world feedback to refine the product before expanding into retail.

AVANT GENOMICS

CHARLOTTESVILLE

Co-founders: Rachelle Turiello (CEO, pictured) and Renna Nouwairi (COO)
Founded: 2023
Capital raised: $3.5 million
Employees: 7
Service provided: Automated sample preparation platform for liquid biopsy

What makes your company different?

Avant Genomics is advancing a first-of-its-kind fully automated sample preparation platform for liquid biopsy. The Avant Source system enables consistent, reliable and efficient collection of tumor-derived cell-free DNA (cfDNA) from a simple blood draw, solving an urgent gap in the detection process. Today, costly and time-consuming manual workflows deliver insufficient cfDNA recovery and variable results, undermining test performance and limiting the utility of liquid biopsy.

The Avant Source platform is distinctly positioned for rapid launch and adoption in a large and growing laboratory market, and Avant Genomics has a seed round near completion and plans to initiate a Series  A round in 2026. Avant is prepared to shift the diagnostic paradigm for cancer detection and monitoring through next-gen automated sample prep.

The pitch: Liquid biopsy will transform cancer care through noninvasive, blood-based diagnostic and treatment monitoring, if we can address the No. 1 bottleneck today: sample preparation. Tedious manual workflows result in inconsistent, unreliable yield of circulating tumor DNA from blood samples.

The solution lies in automation. The Avant Source platform delivers consistently high DNA-yield samples to enable accurate, reliable diagnostic testing. It consolidates dozens of manual steps to just two — load the sample, remove the cartridge — improving yield by nearly 30%, cutting time to result in half and reducing costs by 80%.

Today, there is no fully automated solution across the $1.75 billion U.S. obtainable market. Avant has built momentum on a well-defined path to launch in 2027, with strong infusions of capital, manufacturing underway and market leaders signed up for our early access program. The potential for liquid biopsy to redefine cancer care is at our fingertips — precision starts with preparation.

TIDAL FLIGHT

CHESAPEAKE

Co-founders (from left): Pranav Krishnamurthy (chief technology officer), Mark Lau (chief engineer) and Jude Augustine (CEO)
Founded: 2023
Capital raised: $5.55 million
Employees: 6
Service provided: Hybrid-electric seaplane

What makes your company different?

As compared to other companies in advanced air mobility, our approach of building a fixed-wing seaplane with an existing certification basis under the Federal Aviation Administration’s Part 23 regulations significantly reduces certification risk and cost. Furthermore, since seaplanes are in commercial use today and require very little infrastructure, there is already a robust regulatory framework for seaplane operations and minimal barriers to rapid scaling of seaplane operations.

Polaris is the first hybrid-electric seaplane, reducing operating costs by 50%, reducing fuel burn by 85%, reducing takeoff noise by about 20 decibels and nearly eliminating corrosion-related maintenance. As a hybrid-electric aircraft, Polaris does not depend on charge infrastructure, a critical differentiator over other startups building modern seaplanes that have focused on fully electric or hydrogen-electric solutions.

The pitch: We are building the next enduring aircraft manufacturer around modern propulsion. Our first aircraft is Polaris, a nine- to 12-passenger hybrid-electric amphibious aircraft designed for coastal regional mobility and defense missions. Polaris provides direct access to city centers, vacation destinations and remote communities by landing on the waterways they are built around.

There are 13 billion trips of 100 to 500 miles annually in the U.S. alone, and seaplane access would save 2-plus hours in door-to-door time for those travelers. For the defense sector, Polaris brings low-signature runway independence with a small logistics footprint, critical for potential conflict in the Pacific.

So far, we have flown three one-sixth-scale prototypes, secured more than 150 aircraft and $980 million-plus in orders from 12 airlines, and won a $1.25 million U.S. Air Force contract. We raised $4 million in summer 2025 and are now building full-scale systems, including the full-scale hybrid powertrain and fly-by-wire systems.

QME

CHANTILLY

Co-founders (from left): Aditya Sengar and Akshita Tiwari
Founded: 2022
Capital raised: $0
Employees: 2
Service provided: Quantum computing education

What makes your company different?

Most quantum education content is built for advanced learners or assumes strong coding backgrounds. qMe is designed for first exposure, especially for students who might otherwise self-select out of the field.

Our approach is rooted in behavioral insight: Students don’t disengage because they lack ability, but because they perceive topics as inaccessible. We counter this by anchoring quantum concepts in students’ existing interests, combining storytelling, research and applied learning. As high school founders (now in college), we’ve personally faced this tension, which is why we can connect with students on a closer level.

Additionally, qMe doesn’t stop at education. Students publish blogs, build up their portfolios and begin engaging with real-world innovation early, creating both skill development and identity shifts in who sees themselves in tech.

A portion of profits supports girls’ STEM education in Hyderabad, India. Tiwari started qMe to contribute to a cause she not only relates to but also has witnessed because of her heritage in India.

The pitch: qMe is rethinking how the next generation approaches technology, specifically with quantum computing. While most quantum education is designed by Ph.D.s for advanced learners, qMe is built by students, for students, making complex ideas accessible from the very first exposure.

We’ve taught 300-plus students globally, from elementary school learners to university engineering students, guiding them to complete blog articles and research projects. Our approach builds on student passions, with even a first grader connecting quantum computing to planets. Through partnerships across Charlottesville, Northern Virginia and India, we make abstract concepts engaging and actionable.

qMe isn’t just teaching quantum computing. We’re redefining who gets to learn it.

HERCULE-Q

HAMPTON

Founder and CEO: Hannah LaCon
Founded: 2022
Capital raised: $100,000
Employees: 6
Service provided: Charging infrastructure

What makes your company different?

HerculE-Q differentiates itself by focusing on developing governance-enabled wireless charging infrastructure rather than standalone charging hardware. While many companies in the field are focused solely on improving charging technology, HerculE-Q is building systems that integrate infrastructure, energy coordination and operational oversight into a unified platform.

Additionally, HerculE-Q is focused on enabling flexible and scalable deployment models, particularly in environments where traditional charging infrastructure is difficult to install, such as campuses, urban mobility corridors and shared transportation systems.

By combining wireless charging with infrastructure governance, HerculE-Q is working to support a more integrated and accessible electrified mobility ecosystem.

The pitch: HerculE-Q, with joint venture partner Helixis Technology, is building PWR-ARC, a governance-enabled wireless charging infrastructure designed for the next generation of electrified mobility. As EVs and micromobility scale, the real challenge is no longer just charging — it’s how to deploy and manage charging infrastructure efficiently across cities, campuses and utility systems. PWR-ARC addresses this by combining wireless power transfer with a governance layer that enables operators to monitor, coordinate and scale distributed charging networks.

Our approach reduces infrastructure complexity, lowers installation barriers and supports grid-aligned deployment — making it easier to expand access to charging in high-density and underserved areas. With early traction through university partnerships, engineering development with the New York Institute of Technology and support from NASA and state innovation programs, HerculE-Q is positioned at the intersection of energy, mobility and infrastructure. We are building not just a product, but a platform for scalable electrification.

MECHASTRUCTURE

HAMPTON

Founder and CEO: Iok Wong
Founded: 2025
Capital raised: $50,000
Employees: 1
Service provided: In-space assembly robotic structure

What makes your company different?

Unlike conventional spacecraft, which must be folded tightly to fit within the constraints of a rocket fairing, MechaStructure provides structural systems that enable the construction of mega-scale assets directly in orbit or on the moon. The in-space assembly (ISA) approach facilitates the creation of complex, highly customizable spacecraft architectures that would be difficult, if not impossible, to deploy through conventional methods.

MechaStructure provides an economical, reliable and scalable standardized backbone for next-generation space systems. A core objective is to minimize the barrier to entry for non-aerospace sectors, enabling customers to leverage the unique space environment. By providing managed in-space real estate and utility hosting frameworks, MechaStructure allows commercial and scientific customers to deploy specialized payloads and capabilities without the need to develop an entire spacecraft.

The pitch: The space economy and scientific advancement are accelerating at an unprecedented scale. As reusable rockets lower launch costs, non-aerospace industries are exploring the unique advantages of the space environment. Simultaneously, agencies like NASA are revisiting mega-scale concepts previously limited by rocket fairing volumes. While accessing space was the first hurdle, building and expanding infrastructure is the critical next step for a flourishing orbital economy.

MechaStructure is developing a robotic ISA framework to facilitate the construction of mega-scale spacecraft and orbital assets. The ISA approach achieves superior packing density, enabling massive structures to launch via smaller vehicles while providing flexible mission logistics. Such modularity allows spacecraft and infrastructure to be completed, expanded or upgraded across multiple launch manifests, similar to the International Space Station (ISS). Unlike the ISS, which is human-tended, MechaStructure platforms are operated and managed by the same robots that performed the initial assembly of the platform.

EUNOIA BRA

HENRICO COUNTY

Founder and CEO: Ciara Brown-Smith
Founded: 2024
Capital raised: $5,000
Employees: 1
Service provided: Postpartum support products for women who need to suppress lactation

What makes your company different?

Eunoia Bra was born from a gap that has gone largely unaddressed for decades. When women experience lactation after loss or choose not to breastfeed, they are still being told to use sports bras or plastic wrap — the same advice given 20 years ago. Eunoia Bra is one of the very few products designed specifically for this moment. It combines gentle compression, full coverage and cooling relief in one thoughtful system. More than a product, it’s a brand that centers the emotional experience of postpartum transition — meeting women in grief, in choice and in healing with dignity.

The pitch: When Ciara lost her son, RJ, in 2022, her milk came in days later. She was told to layer multiple sports bras and wrap her chest in plastic wrap just to manage the pain. She then learned this was still the standard advice — the same guidance she’d received 16 years earlier as a teenage mother. So, she built something better.

Eunoia Bra is a postpartum support brand offering a full-coverage compression bra and cooling packs designed for women suppressing lactation — after loss, after choosing not to breastfeed or during weaning. It’s a space that has long been overlooked by the maternity industry.

Derived from ancient Greek, “eunoia” (yoo-noy-uh) means “beautiful thinking” — because even in her most vulnerable moments, every mother deserves a well mind. With a growing online presence and a community that deeply needs this product, Eunoia Bra is just getting started.

INTRAINTEL.AI

FAIRFAX COUNTY

Founder and CEO: Dev Roy
Founded: 2024
Capital raised: $300,000
Employees: 8
Service provided: End-to-end AI platform for enterprise

What makes your company different?

We prove it before you pay for it. Every engagement starts with a free six- to eight-week pilot on your real data, measuring your actual key performance indicators. We don’t sell promises — we sell proven outcomes.

We are an AI systems integrator, not a software vendor. We don’t hand you a platform and wish you luck. We co-build with every customer — capturing their unique workflows, terminology and success patterns — then deploy specialized AI agents tailored to their business.

Our architecture is fundamentally different. Zero data migration means your data never moves. No security risk, no expensive re-platforming, no monthslong implementation.

And finally — we are technology agnostic. As the AI landscape shifts daily, our customers are insulated.

That combination — customer-first proof, deep customization, zero data migration and model agnosticism — is extremely difficult to replicate at speed.

The pitch: IntraIntel.ai is an end-to-end enterprise AI platform — think of one single AI platform with our focus on “your data, your AI, your way,” connecting all different functions within your enterprise. It has 15-plus active deployments across the U.S. and India, $50 million-plus in documented customer value and an over 95% pilot success rate. Unlike point solutions, we replace fragmented “AI in pockets” with a unified, zero-data-migration platform that connects to any existing system in minutes and delivers measurable return on investment in four to eight weeks — with proven 70% to 90% operational time reductions across healthcare, clinical trial, financial services, government, cybersecurity and retail. We’re currently generating early software-as-a-service revenue and targeting $2 million in annual recurring revenue by the end of 2026. We are raising $1.2 million in seed funding to accelerate U.S. enterprise sales and scale our AI agent library.

ALPS DX

RICHMOND

Co-founders (from left):Les Edinboro (chief science officer) and Ali Safavi (president and CEO)
Founded: 2025
Capital raised: $2.2 million
Employees: 8
Service provided: Oral fluid testing automation

What makes your company different?

Alps Dx is redesigning and scaling oral fluid drug testing by automating its most complex and error-prone stages — from collection through sample preparation.

Today, laboratories rely on manual steps to extract, filter and prepare oral fluid samples for analysis. Alps Dx replaces this fragmented workflow with an integrated system of devices, including its Xpressor tool that simplifies sample handling through a two-step filtration and capping process and its Atelier platform that automates barcode tracking, filtration and sample preparation at scale.

By standardizing these steps, Alps Dx reduces manual handling, improves consistency and enables laboratories to scale oral fluid testing more efficiently and reliably.

The company is now expanding beyond the lab with connected collection and verification tools, including its Capra platform, which introduces digital chain-of-custody, identity verification and guided collection.

The pitch: Alps Dx is building automated and connected systems that prepare and verify oral fluid samples for drug testing.

The company is building within a multibillion-dollar drug testing market that is rapidly expanding beyond traditional lab-based methods to include oral fluid and real-world testing environments. This shift is being driven by demand for faster, less invasive and more accessible testing across workplace, clinical and emerging consumer settings.

As the company scales in 2026, Alps Dx is evolving into a platform that supports both high-volume labs and testing that begins in real-world environments, from workplace programs and third-party administrators to public safety and future consumer-facing applications.

By connecting what happens at the point of collection with what happens inside the lab, Alps Dx is helping modernize how drug testing is performed — making it more consistent, scalable and aligned with how testing is used in the real world.

URBAN REBLOK’D

ROANOKE

Founder and president: Joseph Brozovsky
Founded: 2023
Capital raised: $0
Employees: 3
Service provided: Mixed plastics recycling

What makes your company different?

Urban Reblok’d stands apart because we’ve designed our model around the hardest part of the plastic crisis, not the easiest. Most recyclers depend on clean, sorted, high-value plastics, which represent a small fraction of the waste stream. We intentionally target the 91% that is traditionally considered “unrecyclable,” including mixed, contaminated and low-grade plastics.

Our advantage is twofold: feedstock access and process flexibility. Because we accept what others reject, we secure abundant, low-cost (often negative-cost) input supply with minimal competition. At the same time, our processing approach is material-agnostic, allowing us to handle variability without costly pre-sorting infrastructure.

Instead of competing in crowded recycling markets, we’ve created a new category that aligns with tightening regulations and growing demand for circular materials, while unlocking value where others see only waste.

The pitch: Urban Reblok’d is turning America’s most ignored waste stream into a scalable, revenue-generating supply chain. We accept what others reject to convert it into premium, reusable materials for construction and manufacturing applications. We’re paid tipping fees to take in that waste and unlock additional value on the backend, creating a dual-revenue model with strong, defensible margins and contracted supply.

With 100-plus customers and $400,000 in annual recurring revenue, we’ve proven demand, pricing power and operational viability across municipalities and commercial partners.

We are raising $1.5 million to $2 million to launch our first full-scale manufacturing hub in Southwest Virginia, expanding throughput, lowering unit costs and creating regional jobs.

As regulation tightens and brands face recycled-content mandates, demand is accelerating. Plastic waste isn’t going away; we make solving it profitable and scalable, with proprietary processing validated by pilots right now.

HARDSHELL

CHARLOTTESVILLE

Co-founders (from left): Hunter Moore (chief technology officer) and Andrew Schoka (CEO)
Founded: 2025
Capital raised: $1.1 million
Employees: 6
Service provided: AI security platform protecting sensitive datasets

What makes your company different?

Most AI security tools today operate at the model layer, running tests on outputs or filtering prompts after deployment. That means the threats already embedded in the data, like poisoned training sets or leaked sensitive records, go unaddressed. Hardshell works upstream, securing datasets before they enter AI systems. Our platform is model-agnostic, meaning it works across large language models (LLMs), tabular machine learning (ML), computer vision and more, giving security teams a single layer of protection across their entire AI stack.

Our founding team brings a rare combination of technical depth and operational credibility. We built Hardshell because we saw firsthand how sensitive data was being pushed into AI systems without adequate protection, and the existing tools weren’t designed to solve that problem.

The pitch: Organizations in healthcare, defense and financial services are under pressure to adopt AI, but the sensitive data powering those systems remains dangerously exposed. Hardshell secures datasets before they enter AI systems, protecting against threats like data poisoning, data leakage and adversarial manipulation.

We’ve raised over $1.1 million from investors including VTC Ventures, Front Porch Venture Partners, Blu Ventures, Not Yet Ventures and CAV Angels. Our commercial customer base is growing across enterprise verticals, with an active federal pipeline supported by partnerships with defense prime contractors. Our founders bring direct experience from U.S. Cyber Command, U.S. Special Operations Command and the Department of Defense’s Chief Digital and AI Office. Both serve as adjunct faculty at the University of Virginia’s School of Engineering and Applied Science.

Founded in Charlottesville and backed by leading investors across the region, Hardshell is securing the foundation of modern AI.

SYNAP BIOTECH

NORFOLK

President, CEO and co-founder: Glenn Block
Founded: 2023
Capital raised: $115,000
Employees: 2
Service provided: Developing an intranasal therapy to unlock the brain’s ability to repair itself

What makes your company different?

Synap Biotech is focused on neurological recovery, an area that has historically received far less attention than acute treatments or symptom management.

Our approach is different because we are developing a noninvasive intranasal nanobody therapy designed to reach the brain directly and temporarily block biological pathways that prevent nerve regeneration.

By unlocking the brain’s natural capacity for repair, we aim to improve functional recovery after neurological injury. Our platform also has the potential to address multiple conditions — including stroke, traumatic brain injury and neurodegenerative diseases — rather than focusing on a single indication.

The pitch: For millions of patients who survive a stroke or traumatic brain injury, the real challenge begins after the hospital: regaining the ability to move, speak and live independently. Yet few therapies exist that help the brain repair itself once the initial injury has passed.

Synap Biotech is working to change that. Our company is developing a breakthrough intranasal nanobody therapy designed to unlock the brain’s natural ability to recover. The treatment targets Nogo-A and related pathways — molecular signals that act as a brake on nerve regeneration. By temporarily releasing that brake, we aim to enable the brain to rewire and restore lost function.

Delivered through a simple nasal approach that bypasses the blood-brain barrier, our platform has the potential to improve recovery across multiple neurological conditions, including strokes, traumatic brain injuries and neurodegenerative diseases.

At Synap Biotech, our mission is simple: Reimagine what recovery after brain injury can look like.